Background illustration for clinical trials search

Paid Clinical Trials Cincinnati

Discover 1,164 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

US National OCS Heart Perfusion (OHP) Registry

for
Heart Transplant
Location: Cincinnati OH, Lexington KY, Ann Arbor MI, Detroit MI,
Sponsor: TransMedics

Sex: All

Age: 0+

Code: NCT05915299

Recruiting

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

for
Mitral Valve Regurgitation
Location: Cincinnati OH, Columbus OH, Ann Arbor MI, Cleveland OH,
Sponsor: Medtronic Cardiovascular

Sex: All

Age: 18+

Code: NCT03242642

Recruiting

ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves

for
Aortic Valve Insufficiency, Aortic Valve Stenosis
Location: Cincinnati OH, Cleveland OH, Detroit MI, Nashville TN,
Sponsor: Edwards Lifesciences

Sex: All

Age: 0+

Code: NCT05172973

Recruiting

Heparin Intraoperative Instillation for Lower Urinary Tract Symptoms After Benign Hysterectomy

for
Lower Urinary Tract Symptoms,
Location: Cincinnati OH
Sponsor: The Christ Hospital

Sex: Female

Age: 18 - 70+

Code: NCT03633994

Phase2, Recruiting

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Cincinnati OH
Sponsor: Jubilant Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT05268666

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

for
Arterial Disease of Legs, Below-the-knee Obstruction,
Location: Cincinnati OH, Cleveland OH, Davenport IA, Bryn Mawr PA,
Sponsor: Concept Medical Inc.

Sex: All

Age: 21+

Code: NCT06182397

Recruiting

The Fourth Left Atrial Appendage Occlusion Study

for
Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism
Location: Cincinnati OH, Lexington KY, Indianapolis IN, Canton OH,
Sponsor: Hamilton Health Sciences Corporation

Sex: All

Age: 18+

Code: NCT05963698

Recruiting
New

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: Cincinnati OH, Manassas VA, West Des Moines IA,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT07684144

Phase3, Recruiting

Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients

for
Bipolar Depression
Location: Cincinnati OH, Indianapolis IN, Avon Lake OH,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 10 - 17

Code: NCT06372964

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Cincinnati OH, Indianapolis IN, Columbus OH,
Sponsor: Dianthus Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06858579

Phase3, Recruiting

Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

for
Excessive Sleepiness, Shift-work Disorder
Location: Cincinnati OH, Novi MI, Southfield MI, Chicago IL,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06568367

Phase3, Recruiting

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for
Non-Small Cell Lung Cancer
Location: Cincinnati OH, Lexington KY, Columbus OH,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT06767514

Phase3, Recruiting

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Cincinnati OH, Chicago IL, Norcross GA, Snellville GA,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT07484217

Phase3, Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

for
Type 2 Diabetes, Cortisol Excess
Location: Cincinnati OH, Edgewood KY, Columbus OH, Troy MI,
Sponsor: Sparrow Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07296484

Phase2, Recruiting

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer (CRC)
Location: Cincinnati OH, Edgewood KY, Indianapolis IN,
Sponsor: Summit Therapeutics

Sex: All

Age: 18+

Code: NCT07228832

Phase3, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Cincinnati OH, Versailles KY, Beavercreek OH, Dayton OH,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase3, Recruiting

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

for
Endometrial Cancer, Gastric Cancer,
Location: Cincinnati OH, Columbus OH, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05489211

Phase2, Recruiting

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

for
Non-Small Cell Lung Cancer
Location: Cincinnati OH, Noblesville IN, Maumee OH, Toledo OH,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06357533

Phase3, Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Cincinnati OH, Springfield OH, Muncie IN, Evansville IN,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Cincinnati OH, Cleveland OH, Detroit MI, Nashville TN,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting